Assessment Of Vascular Health After Niacin Therapy (AVANT)
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
This study is looking to see if niacin will lessen atherosclerotic plaque inflammation and
favorably affect circulating levels of endothelial progenitor cells and microparticles in
people with atherosclerotic disease on chronic statin therapy.